Artificial Intelligence

7 (Demo)

When will companies stop babysitting the NANNIs for their clinical trials? 5 key takeaways from SCOPE 2020

SCOPE continues to be a central location for industry colleagues to meet and exchange ideas around clinical development. We had a great time at the 2020 meeting catching up with friends, clients and colleagues, as well as co-moderating a roundtable on protocol design and chairing a main session on site selection with esteemed industry practitioners. It was a whirlwind of…


Less artificial…More INTELLIGENCE

In the industry of clinical research, we are accustomed to working with conservative companies that make decisions slowly.  Look at the adoption of EDC – over how many decades now?  Understandable, at least to a point.   I’ve been in my new role at  Phesi for 2 weeks now, and I am witnessing a refreshing change.  Artificial intelligence started to sneak…


A Lot To Be Thankful For

As we head into Thanksgiving, we reflect upon all we have accomplished since January and our vision for 2020. At Phesi, we had quite a few firsts in 2019 and much to be thankful for, such as: Successfully launching our flagship product, ClinSite™ – a self-service, artificial intelligence (AI)-powered tool that enables biopharmaceutical companies to search for and select top-performing…